Verification of nucleotide sequence reagent identities in original publications in high impact factor cancer research journals
P. Pathmendra, Y. Park, F. J. Enguita, J. A. Byrne
This study verifies nucleotide sequence reagents in high-impact cancer journals and finds 3.8% and 4.3% of sequences are wrongly identified in Molecular Cancer and Oncogene papers, respectively.
bioRxiv · Feb 3, 2023Cancer Biology